Cryoablation vs Fascia Iliaca Block for Hip Fracture
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Cryoablation vs Fascia Iliaca Block for Hip Fracture?
Research shows that both the Pericapsular Nerve Group (PENG) block and the Fascia Iliaca Block are used to manage pain in hip fracture patients, with PENG potentially offering better pain control and aiding in faster recovery. Studies suggest that PENG block may be more effective than Fascia Iliaca Block in providing pain relief after hip surgery.12345
Is cryoablation or fascia iliaca block safe for hip fracture treatment?
The studies reviewed focus on the effectiveness of PENG and fascia iliaca blocks for pain management in hip surgeries, but they do not provide specific safety data. However, these techniques are commonly used for their pain-relieving benefits and to reduce the need for opioids, which suggests a level of safety in their application.23456
How does the treatment of Cryoablation of Pericapsular Nerve Group (PENG) differ from other treatments for hip fracture?
Cryoablation of the Pericapsular Nerve Group (PENG) is a novel treatment that uses cold temperatures to target specific nerves around the hip, potentially offering more precise pain relief compared to traditional methods like the Fascia Iliaca Block, which may not provide sufficient analgesia. This approach is unique because it is guided by ultrasound to specifically block the articular branches of the femoral and accessory obturator nerves, which may help reduce the need for opioids and improve early rehabilitation.12345
Research Team
Jason Habeck
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for patients aged 18-85 who are undergoing hip fracture repair. It's not suitable for individuals outside this age range or those with conditions that might interfere with the study.Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cryoablation of the PENG or fascia iliaca catheter for hip fracture repair
Follow-up
Participants are monitored for pain control and opioid use for 30 days post-surgery
Long-term follow-up
Participants' recovery and functional outcomes are assessed
Treatment Details
Interventions
- Cryoablation of Pericapsular Nerve Group (PENG)
- Fascia Iliaca Catheter
Cryoablation of Pericapsular Nerve Group (PENG) is already approved in European Union, United States, Canada for the following indications:
- Pain management in hip fractures
- Solid tumors in lung, liver, kidney, breast, and prostate
- Pain management in hip fractures
- Solid tumors in lung, liver, kidney, breast, and prostate
- Arrhythmias
- Pain management in hip fractures
- Solid tumors in lung, liver, kidney, breast, and prostate
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor